Short Interest in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Decreases By 18.0%

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the target of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 33,700 shares, a decrease of 18.0% from the September 30th total of 41,100 shares. Based on an average trading volume of 521,500 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.7% of the company’s stock are sold short.

Shuttle Pharmaceuticals Price Performance

Shares of NASDAQ:SHPH opened at $1.25 on Monday. Shuttle Pharmaceuticals has a 1 year low of $1.03 and a 1 year high of $4.95. The stock has a fifty day simple moving average of $1.54.

Shuttle Pharmaceuticals (NASDAQ:SHPH) last issued its quarterly earnings data on Tuesday, September 3rd. The company reported ($0.96) earnings per share (EPS) for the quarter.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .